Sinopharm Group Co. (01099.HK) and Merck (China) (MRK.N) met in Shanghai to discuss the potential appointment of Sinopharm as exclusive import/distribution agent for innovative drug Xinrulai® and related post-launch cooperation. The parties agreed to deepen strategic collaboration to improve access to rare-disease therapies and commercialization efficiency in China.

2026-07-09

Sinopharm Group Co. (01099.HK) and Merck (China) (MRK.N) met in Shanghai to discuss the potential appointment of Sinopharm as exclusive import/distribution agent for innovative drug Xinrulai® and related post-launch cooperation. The parties agreed to deepen strategic collaboration to improve access to rare-disease therapies and commercialization efficiency in China.